CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 8.75p |
Change Today | -0.27p |
% Change | -2.99 % |
52 Week High | 10.20 |
52 Week Low | 2.95 |
Volume | 876,265 |
Shares Issued | 113.66m |
Market Cap | £9.94m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:30 | 4,765 @ 8.50p |
16:10 | 40,000 @ 8.11p |
15:55 | 5,800 @ 8.50p |
15:52 | 40,000 @ 8.20p |
15:34 | 6 @ 8.80p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research